Hospira Australia Pty Ltd develops and manufactures generic injectable pharmaceuticals. It offers generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions for the treatment of cardiovascular, anesthesia, anti-infectives, oncology, analgesics, emergency, and other areas. The company also provides a range of products and services, including specialist hospital products, general infusion and pain management pumps, waste disposal systems, and needleless administration equipment; and Hospira MedNet, a drug-dose safety software that helps reduce medication errors by working to improve the intravenous medication administration process. ...
500 Collins Street
Melbourne, VIC 3000
Founded in 2001
61 3 0004 6774
61 8 0064 4810
Hospira Australia Pty Ltd Announces Executive Appointments
Jul 31 14
Hospira Australia Pty Ltd. has announced two new recruits for its leadership team in the roles of sales director, ANZ, and regulatory associate director, ANZ. John Spilman, sales director, ANZ, brings more than 25 years of experience in sales and marketing to the role, and has been with Hospira since it was founded in 2004. Most recently, he held the role of director of National Account Sales and Marketing in Hospira’s U.S. business. Mary Nteris, regulatory associate director, ANZ, comes to Hospira from INC Research, where she held the role of Director, Global Regulatory Consulting (APAC, excl. Japan). Both roles will report to Mark Crotty, vice president, Hospira ANZ.